AE Wealth Management LLC Purchases Shares of 2,651 Express Scripts Holding Co (ESRX)
AE Wealth Management LLC purchased a new position in Express Scripts Holding Co (NASDAQ:ESRX) in the 2nd quarter, Holdings Channel reports. The fund purchased 2,651 shares of the company’s stock, valued at approximately $205,000.
Several other institutional investors and hedge funds also recently bought and sold shares of ESRX. BlackRock Inc. increased its holdings in Express Scripts by 1.5% in the 2nd quarter. BlackRock Inc. now owns 35,424,185 shares of the company’s stock worth $2,735,103,000 after buying an additional 538,578 shares in the last quarter. Hendershot Investments Inc. increased its holdings in Express Scripts by 2.7% in the 2nd quarter. Hendershot Investments Inc. now owns 89,125 shares of the company’s stock worth $6,881,000 after buying an additional 2,380 shares in the last quarter. Commonwealth Bank of Australia increased its holdings in Express Scripts by 15.6% in the 2nd quarter. Commonwealth Bank of Australia now owns 296,858 shares of the company’s stock worth $22,915,000 after buying an additional 39,983 shares in the last quarter. Stock Yards Bank & Trust Co. bought a new stake in Express Scripts in the 2nd quarter worth about $1,084,000. Finally, Marco Investment Management LLC increased its holdings in Express Scripts by 168.2% in the 2nd quarter. Marco Investment Management LLC now owns 79,246 shares of the company’s stock worth $6,119,000 after buying an additional 49,696 shares in the last quarter. 84.73% of the stock is owned by hedge funds and other institutional investors.
Several equities research analysts recently commented on the company. ValuEngine upgraded Express Scripts from a “hold” rating to a “buy” rating in a report on Monday. Robert W. Baird downgraded Express Scripts from an “outperform” rating to a “neutral” rating and set a $81.00 price objective for the company. in a report on Friday, July 20th. BidaskClub upgraded Express Scripts from a “hold” rating to a “buy” rating in a research note on Wednesday, June 13th. William Blair upgraded Express Scripts from a “market perform” rating to an “outperform” rating in a research note on Wednesday, August 1st. Finally, Zacks Investment Research downgraded Express Scripts from a “hold” rating to a “sell” rating in a research note on Monday, July 23rd. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and six have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $85.58.
Express Scripts (NASDAQ:ESRX) last released its quarterly earnings results on Wednesday, August 1st. The company reported $2.22 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.20 by $0.02. The business had revenue of $25.64 billion during the quarter, compared to the consensus estimate of $25.43 billion. Express Scripts had a return on equity of 25.49% and a net margin of 4.65%. The business’s quarterly revenue was up 1.2% compared to the same quarter last year. During the same period in the previous year, the company posted $1.73 EPS. sell-side analysts expect that Express Scripts Holding Co will post 9.07 earnings per share for the current fiscal year.
In related news, insider Christine Houston sold 12,898 shares of the business’s stock in a transaction that occurred on Friday, August 10th. The stock was sold at an average price of $85.00, for a total transaction of $1,096,330.00. Following the completion of the transaction, the insider now directly owns 110,908 shares in the company, valued at approximately $9,427,180. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 0.79% of the company’s stock.
Express Scripts Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Further Reading: Diversification in Investing
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.